Author

M. D'Amato

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

A. De Luigi· 1 shared A. Ocklind· 1 shared A. T. Adams· 1 shared C. Olbjorn· 1 shared C. Petren· 1 shared D. Bergemalm· 1 shared D. Lilleri· 1 shared D. Repsilber· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. De Luigi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Neutrophil extracellular traps induce the epithelial-mesenchymal transition: implications in post-COVID-19 fibrosis

L. Pandolfi, S. Bozzini, F. Vanessa, E. Percivalle, A. De Luigi, M. B. Violatto, G. Lopez, E. Gabanti, L. Carsana, M. D'Amato, M. Morosini, M. De Amici, M. Nebuloni, T. Fossali, R. Colombo, , F. Meloni

This study shows that neutrophil extracellular traps (NETs) induce epithelial-mesenchymal transition (EMT) in lung cells, contributing to post-COVID-19 fibrosis.

bioRxiv · Nov 9, 2020Immunology

Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease.

R. Kalla, A. T. Adams, D. Bergemalm, S. Vatn, N. A. Kennedy, P. Ricanek, J. C. Lindstrom, A. Ocklind, F. Hjelm, N. T. Ventham, G.-T. Ho, C. Petren, IBD Character Consortium, D. Repsilber, J. D. Soderholm, , J. Satsangi

This study identifies a serum protein panel that distinguishes inflammatory bowel disease from non-IBD controls and predicts treatment escalation.

bioRxiv · Aug 31, 2020Immunology